OpenURL Connection Search

Select item for more details and to access through your institution.

Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer.
Published in:
In Vivo, 2020, v. 34, n. 5, p. 2997, doi. 10.21873/invivo.12131
By:
- TSUKASA HASEGAWA;
- NORIKO YANAGITANI;
- HIRONORI NINOMIYA;
- HIROAKI SAKAMOTO;
- TAKEHIRO TOZUKA;
- HIROSHI YOSHIDA;
- YOSHIAKI AMINO;
- SHINYA UEMATSU;
- TAKAHIRO YOSHIZAWA;
- RYO ARIYASU;
- KEN UCHIBORI;
- SATORU KITAZONO;
- ATSUSHI HORIIKE;
- MAKOTO NISHIO
Publication type:
Article
Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib.
Published in:
Cancer Reports, 2021, v. 4, n. 6, p. 1, doi. 10.1002/cnr2.1414
By:
- Sakamoto, Hiroaki;
- Yanagitani, Noriko;
- Manabe, Ryo;
- Tsugitomi, Ryosuke;
- Ogusu, Shinsuke;
- Tozuka, Takehiro;
- Yoshida, Hiroshi;
- Amino, Yoshiaki;
- Ariyasu, Ryo;
- Uchibori, Ken;
- Kitazono, Satoru;
- Tasaka, Sadatomo;
- Nishio, Makoto
Publication type:
Article
A case of Churg-Strauss syndrome complicated with bilateral central retinal artery occlusion.
Published in:
Chest Disease Reports, 2013, v. 3, n. 1, p. 1, doi. 10.4081/cdr.2013.e1
By:
- Ken Uchibori;
- Emi Shinohara;
- Haruhiko Furusawa;
- Shinichiro Tominaga;
- Ichiro Natsume;
- Minoru Ohkouchi
Publication type:
Article
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors.
Published in:
2020
By:
- Tozuka, Takehiro;
- Kitazono, Satoru;
- Sakamoto, Hiroaki;
- Yoshida, Hiroshi;
- Amino, Yoshiaki;
- Uematsu, Shinya;
- Yoshizawa, Takahiro;
- Hasegawa, Tsukasa;
- Uchibori, Ken;
- Yanagitani, Noriko;
- Horiike, Atsushi;
- Horai, Takeshi;
- Seike, Masahiro;
- Gemma, Akihiko;
- Nishio, Makoto
Publication type:
journal article
Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients.
Published in:
Investigational New Drugs, 2023, v. 41, n. 3, p. 411, doi. 10.1007/s10637-023-01358-3
By:
- Tozuka, Takehiro;
- Yanagitani, Noriko;
- Yoshida, Hiroshi;
- Manabe, Ryo;
- Ogusu, Shinsuke;
- Tsugitomi, Ryosuke;
- Sakamoto, Hiroaki;
- Amino, Yoshiaki;
- Ariyasu, Ryo;
- Uchibori, Ken;
- Kitazono, Satoru;
- Seike, Masahiro;
- Gemma, Akihiko;
- Nishio, Makoto
Publication type:
Article
EGFR-TKI re-administration after osimertinib failure in T790M mutation loss cases with re-biopsy.
Published in:
Investigational New Drugs, 2022, v. 40, n. 6, p. 1342, doi. 10.1007/s10637-022-01301-y
By:
- Ogusu, Shinsuke;
- Ariyasu, Ryo;
- Akita, Takahiro;
- Kiritani, Ayu;
- Tsugitomi, Ryosuke;
- Amino, Yoshiaki;
- Uchibori, Ken;
- Kitazono, Satoru;
- Yanagitani, Noriko;
- Nishio, Makoto
Publication type:
Article
Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer.
Published in:
International Journal of Clinical Oncology, 2021, v. 26, n. 3, p. 507, doi. 10.1007/s10147-020-01822-7
By:
- Hasegawa, Tsukasa;
- Yanagitani, Noriko;
- Ohyanagi, Fumiyoshi;
- Kudo, Keita;
- Horiike, Atsushi;
- Tambo, Yuichi;
- Nishikawa, Shingo;
- Ariyasu, Ryo;
- Uchibori, Ken;
- Kitazono, Satoru;
- Nishio, Makoto
Publication type:
Article
Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC.
Published in:
International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 67, doi. 10.1007/s10147-019-01537-4
By:
- Amino, Yoshiaki;
- Kitazono, Satoru;
- Uematsu, Shinya;
- Hasegawa, Tsukasa;
- Yoshizawa, Takahiro;
- Uchibori, Ken;
- Yanagitani, Noriko;
- Horiike, Atsushi;
- Horai, Takeshi;
- Kasahara, Kazuo;
- Nishio, Makoto
Publication type:
Article
Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer.
Published in:
2018
By:
- Masafumi Saiki;
- Satoru Kitazono;
- Takahiro Yoshizawa;
- Yosuke Dotsu;
- Ryo Ariyasu;
- Junji Koyama;
- Tomoaki Sonoda;
- Ken Uchibori;
- Shingo Nishikawa;
- Noriko Yanagitani;
- Atsushi Horiike;
- Fumiyoshi Ohyanagi;
- Katsunori Oikado;
- Hironori Ninomiya;
- Kengo Takeuchi;
- Yuichi Ishikawa;
- Makoto Nishio;
- Saiki, Masafumi;
- Kitazono, Satoru;
- Yoshizawa, Takahiro
Publication type:
journal article
Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer.
Published in:
Nature Communications, 2017, v. 8, n. 3, p. 14768, doi. 10.1038/ncomms14768
By:
- Uchibori, Ken;
- Inase, Naohiko;
- Araki, Mitsugu;
- Kamada, Mayumi;
- Sato, Shigeo;
- Okuno, Yasushi;
- Fujita, Naoya;
- Katayama, Ryohei
Publication type:
Article
Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.
Published in:
Thoracic Cancer, 2024, v. 15, n. 10, p. 788, doi. 10.1111/1759-7714.15268
By:
- Takahiro Akita;
- Ryo Ariyasu;
- Sho Kakuto;
- Keiki Miyadera;
- Ayu Kiritani;
- Ryosuke Tsugitomi;
- Yoshiaki Amino;
- Ken Uchibori;
- Satoru Kitazono;
- Noriko Yanagitani;
- Sadatomo Tasaka;
- Makoto Nishio
Publication type:
Article
Efficacy of osimertinib in patients with EGFR‐mutation positive non‐small cell lung cancer with malignant pleural effusion.
Published in:
Thoracic Cancer, 2024, v. 15, n. 5, p. 402, doi. 10.1111/1759-7714.15210
By:
- Kiritani, Ayu;
- Amino, Yoshiaki;
- Uchibori, Ken;
- Akita, Takahiro;
- Harutani, Yuhei;
- Ogusu, Shinsuke;
- Tsugitomi, Ryosuke;
- Manabe, Ryo;
- Ariyasu, Ryo;
- Kitazono, Satoru;
- Yanagitani, Noriko;
- Nishio, Makoto
Publication type:
Article
Clinical characteristics of patients with KRAS mutation detected by liquid biopsy.
Published in:
Thoracic Cancer, 2023, v. 14, n. 33, p. 3317, doi. 10.1111/1759-7714.15123
By:
- Yoshiaki Amino;
- Siew-Kee Low;
- Hironori Ninomiya;
- Ayu Kiritani;
- Keiki Miyadera;
- Sho Kakuto;
- Takahiro Akita;
- Ryosuke Tsugitomi;
- Ryo Ariyasu;
- Ken Uchibori;
- Satoru Kitazono;
- Noriko Yanagitani;
- Makoto Nishio
Publication type:
Article
Clinical characteristics of patients with KRAS mutation detected by liquid biopsy.
Published in:
Thoracic Cancer, 2023, v. 14, n. 31, p. 3317, doi. 10.1111/1759-7714.15123
By:
- Amino, Yoshiaki;
- Low, Siew‐Kee;
- Ninomiya, Hironori;
- Kiritani, Ayu;
- Miyadera, Keiki;
- Kakuto, Sho;
- Akita, Takahiro;
- Tsugitomi, Ryosuke;
- Ariyasu, Ryo;
- Uchibori, Ken;
- Kitazono, Satoru;
- Yanagitani, Noriko;
- Nishio, Makoto
Publication type:
Article
A phase II feasibility study of carboplatin and nab‐paclitaxel for advanced non‐small cell lung cancer patients with interstitial lung disease (YLOG0114).
Published in:
Thoracic Cancer, 2022, v. 13, n. 9, p. 1267, doi. 10.1111/1759-7714.14376
By:
- Sakashita, Hiroyuki;
- Uchibori, Ken;
- Jin, Yasuto;
- Tsutsui, Toshiharu;
- Honda, Takayuki;
- Sakakibara, Rie;
- Mitsumura, Takahiro;
- Nukui, Yoshihisa;
- Shirai, Tsuyoshi;
- Masuo, Masahiro;
- Suhara, Kozo;
- Furusawa, Haruhiko;
- Yamashita, Takaaki;
- Ohba, Takehiko;
- Saito, Kazuhito;
- Takagiwa, Jun;
- Miyashita, Yoshihiro;
- Inase, Naohiko;
- Miyazaki, Yasunari
Publication type:
Article
Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2.
Published in:
Thoracic Cancer, 2021, v. 12, n. 6, p. 906, doi. 10.1111/1759-7714.13797
By:
- Uchibori, Ken;
- Takano, Natsuki;
- Manabe, Ryo;
- Tsugitomi, Ryosuke;
- Ogusu, Shinsuke;
- Tozuka, Takehiro;
- Sakamoto, Hiroaki;
- Yoshida, Hiroshi;
- Amino, Yoshiaki;
- Ariyasu, Ryo;
- Kitazono, Satoru;
- Yanagitani, Noriko;
- Nishio, Makoto
Publication type:
Article
Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice.
Published in:
Thoracic Cancer, 2021, v. 12, n. 4, p. 504, doi. 10.1111/1759-7714.13786
By:
- Ariyasu, Ryo;
- Uchibori, Ken;
- Ninomiya, Hironori;
- Ogusu, Shinsuke;
- Tsugitomi, Ryosuke;
- Manabe, Ryo;
- Sakamaoto, Hiroaki;
- Tozuka, Takehiro;
- Yoshida, Hiroshi;
- Amino, Yoshiaki;
- Kitazono, Satoru;
- Yanagitani, Noriko;
- Takeuchi, Kengo;
- Nishio, Makoto
Publication type:
Article
Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases.
Published in:
Thoracic Cancer, 2020, v. 11, n. 9, p. 2465, doi. 10.1111/1759-7714.13557
By:
- Tozuka, Takehiro;
- Kitazono, Satoru;
- Sakamoto, Hiroaki;
- Yoshida, Hiroshi;
- Amino, Yoshiaki;
- Uematsu, Shinya;
- Yoshizawa, Takahiro;
- Hasegawa, Tsukasa;
- Ariyasu, Ryo;
- Uchibori, Ken;
- Yanagitani, Noriko;
- Horai, Takeshi;
- Seike, Masahiro;
- Gemma, Akihiko;
- Nishio, Makoto
Publication type:
Article
Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer.
Published in:
Thoracic Cancer, 2020, v. 11, n. 3, p. 581, doi. 10.1111/1759-7714.13299
By:
- Takahashi, Ken;
- Seto, Yosuke;
- Okada, Koutaroh;
- Uematsu, Shinya;
- Uchibori, Ken;
- Tsukahara, Mika;
- Oh‐hara, Tomoko;
- Fujita, Naoya;
- Yanagitani, Noriko;
- Nishio, Makoto;
- Okubo, Kenichi;
- Katayama, Ryohei
Publication type:
Article
Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms.
Published in:
2020
By:
- Ariyasu, Ryo;
- Yanagitani, Noriko;
- Tadokoro, Kenichi;
- Yamaguchi, Toshikazu;
- Uchibori, Ken;
- Kitazono, Satoru;
- Fujita, Naoya;
- Katayama, Ryohei;
- Nishio, Makoto
Publication type:
journal article
GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer.
Published in:
NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00260-0
By:
- Shimizu, Yuki;
- Okada, Koutaroh;
- Adachi, Jun;
- Abe, Yuichi;
- Narumi, Ryohei;
- Uchibori, Ken;
- Yanagitani, Noriko;
- Koike, Sumie;
- Takagi, Satoshi;
- Nishio, Makoto;
- Fujita, Naoya;
- Katayama, Ryohei
Publication type:
Article
Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity.
Published in:
NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00170-7
By:
- Yoshizawa, Takahiro;
- Uchibori, Ken;
- Araki, Mitsugu;
- Matsumoto, Shigeyuki;
- Ma, Biao;
- Kanada, Ryo;
- Seto, Yosuke;
- Oh-hara, Tomoko;
- Koike, Sumie;
- Ariyasu, Ryo;
- Kitazono, Satoru;
- Ninomiya, Hironori;
- Takeuchi, Kengo;
- Yanagitani, Noriko;
- Takagi, Satoshi;
- Kishi, Kazuma;
- Fujita, Naoya;
- Okuno, Yasushi;
- Nishio, Makoto;
- Katayama, Ryohei
Publication type:
Article
A case of Muckle–Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin).
Published in:
Modern Rheumatology, 2007, v. 17, n. 6, p. 496, doi. 10.3109/s10165-007-0616-5
By:
- Koike, Ryuji;
- Kubota, Tetsuo;
- Hara, Yukichi;
- Ito, Sayaka;
- Suzuki, Kyoko;
- Yanagisawa, Kayoko;
- Uchibori, Ken;
- Miyasaka, Nobuyuki
Publication type:
Article
Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR.
Published in:
Cancer Science, 2021, v. 112, n. 6, p. 2371, doi. 10.1111/cas.14879
By:
- Ariyasu, Ryo;
- Uchibori, Ken;
- Sasaki, Takaaki;
- Tsukahara, Mika;
- Kiyotani, Kazuma;
- Yoshida, Ryohei;
- Ono, Yusuke;
- Kitazono, Satoru;
- Ninomiya, Hironori;
- Ishikawa, Yuichi;
- Mizukami, Yusuke;
- Yanagitani, Noriko;
- Fujita, Naoya;
- Nishio, Makoto;
- Katayama, Ryohei
Publication type:
Article
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms.
Published in:
Cancer Science, 2020, v. 111, n. 3, p. 932, doi. 10.1111/cas.14314
By:
- Yanagitani, Noriko;
- Uchibori, Ken;
- Koike, Sumie;
- Tsukahara, Mika;
- Kitazono, Satoru;
- Yoshizawa, Takahiro;
- Horiike, Atsushi;
- Ohyanagi, Fumiyoshi;
- Tambo, Yuichi;
- Nishikawa, Shingo;
- Fujita, Naoya;
- Katayama, Ryohei;
- Nishio, Makoto
Publication type:
Article
Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients.
Published in:
Cancer Science, 2019, v. 110, n. 10, p. 3350, doi. 10.1111/cas.14153
By:
- Kitazono, Satoru;
- Sakai, Kazuko;
- Yanagitani, Noriko;
- Ariyasu, Ryo;
- Yoshizawa, Takahiro;
- Dotsu, Yosuke;
- Koyama, Junji;
- Saiki, Masafumi;
- Sonoda, Tomoaki;
- Nishikawa, Shingo;
- Uchibori, Ken;
- Horiike, Atsushi;
- Nishio, Kazuto;
- Nishio, Makoto
Publication type:
Article
Lung Cancer Diagnosed More Than Five Years after the Development of Polymyositis/Dermatomyositis.
Published in:
2013
By:
- Uchibori, Ken;
- Ogata, Tomoyuki;
- Shirai, Tuyoshi;
- Yamauchi, Shuta;
- Masuo, Masahiro;
- Chiba, Sahoko;
- Furusawa, Haruhiko;
- Tsuchiya, Kimitake;
- Fujie, Toshihide;
- Tamaoka, Meiyo;
- Sakashita, Hiroyuki;
- Sumi, Yuki;
- Miyazaki, Yasunari;
- Inase, Naohiko
Publication type:
Journal Article
Lung Cancer Diagnosed More Than Five Years after the Development of Polymyositis/Dermatomyositis.
Published in:
ISRN Pulmonology, 2013, p. 1, doi. 10.1155/2013/409862
By:
- Uchibori, Ken;
- Ogata, Tomoyuki;
- Shirai, Tuyoshi;
- Yamauchi, Shuta;
- Masuo, Masahiro;
- Chiba, Sahoko;
- Furusawa, Haruhiko;
- Tsuchiya, Kimitake;
- Fujie, Toshihide;
- Tamaoka, Meiyo;
- Sakashita, Hiroyuki;
- Sumi, Yuki;
- Miyazaki, Yasunari;
- Inase, Naohiko
Publication type:
Article

Found: 28